Gene description for HLA-DRA
Gene name major histocompatibility complex, class II, DR alpha
Gene symbol HLA-DRA
Other names/aliases HLA-DRA1
Species Homo sapiens
 Experiment description of studies that identified HLA-DRA in Ascites

1
Experiment ID56
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Immunoelectron Microscopy
Western blotting
PubMed ID 12147373   
OrganismHomo sapiens
Experiment descriptionMalignant effusions and immunogenic tumour-derived exosomes.
AuthorsAndre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L
Journal name LANCET
Publication year2002
SampleAscites
Sample nameMalignant ascites
Isolation/purification methodsDifferential centrifugation
Sucrose density gradient
Flotation density1.14-1.18 g/mL
Molecules identified in the studyProtein
Methods used in the studyWestern blotting
EV-TRACK -

2
Experiment ID108
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Western blotting
PubMed ID 21601258   
OrganismHomo sapiens
Experiment descriptionLoss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage.
AuthorsRupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marmé, Sün H, Altevogt P.
Journal name GO
Publication year2011
SampleAscites
Sample nameMalignant ascites - ovarian cancer
Isolation/purification methodsDifferential centrifugation
Sucrose density gradient
Immunobeads (EpCAM, CD24)
Flotation density1.04-1.15 g/mL
Molecules identified in the studyProtein
miRNA
Methods used in the studyWestern blotting
Immunoelectron microscopy
EV-TRACK EV110020: EV-METRIC:13%, 63%, 50%

3
Experiment ID110
Identified moleculeprotein
Extracellular vesicle typeExosomes
MISEVEVs
Identification method Western blotting
PubMed ID 21601258   
OrganismHomo sapiens
Experiment descriptionLoss of EpCAM expression in breast cancer derived serum exosomes: Role of proteolytic cleavage.
AuthorsRupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, Moldenhauer G, Marmé, Sün H, Altevogt P.
Journal name GO
Publication year2011
SampleAscites
Sample nameAscites - liver cirrhosis
Isolation/purification methodsDifferential centrifugation
Sucrose density gradient
Flotation density1.04-1.10 g/mL
Molecules identified in the studyProtein
miRNA
Methods used in the studyWestern blotting
Immunoelectron microscopy
EV-TRACK EV110020: EV-METRIC:13%, 63%, 50%

4
Experiment ID159
Identified moleculeprotein
Extracellular vesicle typeMicrovesicles
MISEVEVs
Identification method Mass spectrometry [LTQ]
PubMed ID 21630462   
OrganismHomo sapiens
Experiment descriptionProteomic analysis of microvesicles derived from human colorectal cancer ascites
AuthorsChoi DS, Park JO, Jang SC, Yoon YJ, Jung JW, Choi DY, Kim JW, Kang JS, Park J, Hwang D, Lee KH, Park SH, Kim YK, Desiderio DM, Kim KP, Gho YS
Journal name Proteomics
Publication year2011
SampleAscites
Sample nameMalignant ascites - Colorectal cancer patient 3
Isolation/purification methodsDifferential centrifugation
Sucrose density gradient
OptiPrep density gradient
Flotation density1.09 g/mL
Molecules identified in the studyProtein
Methods used in the studyMass spectrometry [LTQ]
EV-TRACK EV110017: EV-METRIC:38%

<